Please login to the form below

Not currently logged in
Email:
Password:

Frank Pieters leaves Teva to lead Cipla’s respiratory business

Will head up attempt to capitalise on the expiry of major pharma patents, such as that of GSK's Advair

Frank Pieters has left Teva Pharmaceutical to join India-based generics company Cipla as head of its European region and global respiratory business.

Pieters was most recently senior VP Southern Europe at Israel-based Teva – the largest generics company in the world.

His latest move signals an intent from Cipla to take advantage of the patent expiries for leading respiratory products, including GlaxoSmithKline's (GSK) Advair, which Cipla has a generic version.

“With [Pieters] at the helm, Cipla would like to capture the huge commercial upside of 30 years experience in Cipla's respiratory medicine; both in emerging and regulated markets,” said Dr Yusuf Hamied, chairman and managing director, Cipla.

“This appointment signals Cipla's strengthening of senior management positions and also illustrates Cipla's desire for senior on-ground talent in overseas markets to build its product portfolio and brand.”

During his time at Teva, Pieters also served as senior VP global biogenerics and global respiratory commercial business and he was also a member of the TEVA-Lonza Joint Steering Committee.

From 1989 to 2004, he held several senior positions at GSK, including VP and general manager.

6th July 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Strategic North

Strategic North is an insight driven healthcare strategic marketing agency, which offers you something a little bit different. Our purpose...

Latest intelligence

Easier access to medicines in the UK?
Cutting through the NICE value-based assessment consultation to find out what’s at stake...
Exploring MINT: Part 3 - Nigeria
In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria....
BL_Where_Now_20140721_CoverImage.jpg
3 Steps to Navigating Multichannel in Healthcare
You know about multichannel, but... where now? Download the 3 Steps to Navigating Multichannel in Healthcare ebook to learn what you should do next when planning your multichannel campaign....